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A B S T R A C T   
The increase of obesity coincides with a substantial decrease in cigarette smoking. We assessed post-cessation 
weight change and its contribution to the obesity epidemic in a general population in Norway. A total of 
14,453 participants (52.6% women), aged 25–54 years in 1994, who attended at least two of four surveys in the 
Tromsø Study between 1994 and 2016, were included in the analysis. Hereof 77% participated in both the first 
and the last survey. 
Temporal trends in mean body mass index (BMI), prevalence of obesity (BMI ≥ 30 kg/m2) and daily smoking 
were estimated with generalized estimation equations. We assessed BMI change by smoking status (ex-smoker, 
quitter, never smoker, daily smoker), and also under a scenario where none quit smoking. 
In total, the prevalence of daily smoking was reduced over the 21 years between Tromsø 4 (1994–1995) and 
Tromsø 7 (2015–2016) by 22 percentage points. Prevalence of obesity increased from 5 – 12% in 1994–1995 to 
21–26% in 2015–2016, where obesity in the youngest (age 25–44 in 1994) increased more than in the oldest 
(p < 0.0001). Those who quit smoking had a larger BMI gain compared to the other three smoking subgroups 
over the 21 years (p < 0.0001). The scenario where none quit smoking would imply a 13% reduction in BMI gain 
in the population, though substantial age-related differences were noted. 
We conclude that smoking cessation contributed to the increase in obesity in the population, but was probably 
not the most important factor. Public health interventions should continue to target smoking cessation, and also 
target obesity prevention.   
1. Introduction 
Tobacco smoking is the cause of millions of deaths and cases of 
chronic diseases worldwide every year (World Health Organization, 
2020). The Global Burden of Disease project estimated that 7.1 million 
deaths and 182 million disability-adjusted life years (DALYs) could be 
attributed to this single risk factor in 2017, with only high systolic blood 
pressure causing more life years lost (Stanaway et al., 2018). 
Obesity is a risk factor for diabetes, musculoskeletal disorders, some 
cancers, cardiovascular and kidney diseases (NCD Risk Factor Collabo-
ration, 2016). There is some evidence that obesity also increases the risk 
for hospitalization and death from the infectious diseases H1N1 (swine 
influenza) and COVID-19 (Dietz and Santos-Burgoa, 2020). In a recent 
Mendelian randomization study, tobacco smoking and elevated body 
mass index (BMI) were found to be associated with an increased risk of 
severe COVID-19 (Ponsford et al., 2020). 
Progress has been made to reduce the number of smokers, with a 
decline in every region of the world (World Health Organization, 2019). 
At the same time, there has been an increase in the prevalence of obesity. 
The fact that the prevalence of these two risk factors have moved in 
opposite directions motivated the research question “Is the ongoing 
obesity epidemic partly explained by concurrent decline in cigarette 
smoking?” 
Several longitudinal population studies, with a follow-up time of 4 to 
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11 years, have found that quitting smoking is associated with an 
excessive weight gain (Clair et al., 2013; Janzon et al., 2004; Lycett 
et al., 2011; Sneve and Jorde, 2008; Tamura et al., 2010; Travier et al., 
2012; Williamson et al., 1991). We assessed this hypothesis over 
21 years of follow-up. A time scale of two decades has previously been 
used in only one study (Jain et al., 2016), though the focus of Jain et al. 
was on long-term post-cessation weight, whereas we also aim to quantify 
the impact of smoking cessation on the obesity epidemic. Furthermore, 
we will also assess the short-term (a few years) post-cessation weight 
change, using data from a large longitudinal population study. 
2. Materials and methods 
2.1. Study population 
The Tromsø Study is an ongoing population based study, established 
in 1974, with participants recruited from Tromsø, the largest populated 
municipality in Northern Norway, consisting of both urban and rural 
living areas. 
We used data from the fourth to seventh survey: Tromsø 4 was 
conducted in 1994–1995, Tromsø 5 in 2001, Tromsø 6 in 2007–2008 
and Tromsø 7 in 2015–2016. A total of 36,929 men and women 
participated in at least one of these four surveys, 19,965 in at least two. 
The attendance ranged from 65% to 79%. All inhabitants above a certain 
age were invited to Tromsø 4 (aged 25 and above) and Tromsø 7 (aged 
40 and above). Representative samples were invited to Tromsø 5 and 6 
(Eggen et al., 2013; Jacobsen et al., 2012). 
In the present analyses we included participants born in 1940–1969, 
aged 25–54 years in 1994. We included subjects that attended at least 
two surveys (n = 14,789), excluding those who withdrew their consent 
to research (n = 19) and those with missing data on smoking (n = 112), 
BMI (n = 202) or both (n = 3), resulting in a final sample of 14,453 
participants (52.6% women). Herein 52% participated in two, 37% in 
three and 11% in all four surveys, 77% participated in both Tromsø 4 
and Tromsø 7, 20% in Tromsø 4 and 5, 14% in Tromsø 5 and 6 and 50% 
in Tromsø 6 and 7. A lasagna plot (Jones et al., 2014) of the joint dis-
tribution of attendance is found in Supplementary Fig. 1. Supplementary 
Table 1 shows the sample size by birth cohort and sex. 
The Regional Committee of Medical and Health Research Ethics 
(REK Nord 2014/940) and the Norwegian Data Protection Authority 
approved the Tromsø Study, and the participants gave written informed 
consent. 
2.2. Anthropometric measurements 
Height and weight were measured with light clothing and no foot-
wear, to the nearest 1 cm and 0.5 kg in Tromsø 4, and to the nearest 
0.1 cm and 0.1 kg in Tromsø 5–7, respectively. All measurements with 
remarks, e.g., pregnancy, scoliosis or measured with shoes, were set to 
missing. BMI was calculated as weight/height2 (kg/m2), and obesity 
defined as BMI ≥ 30 kg/m2. 
2.3. Smoking status 
In Tromsø 5–7 the question “Do you/did you smoke daily?” was to be 
answered by one of the three alternatives; “Yes, now”, “Yes, previously”, 
“Never”. For Tromsø 4 we constructed a binary variable about daily 
smoking (yes/no) from the three questions; “Do you smoke: Cigarettes 
daily? Cigars/cigarillos daily? A pipe daily?”. If none of these three 
questions were answered, daily smoking (in Tromsø 4) was set to 
missing. If at least one of the answers was yes, then daily smoking was 
set to yes, otherwise no. 
Smoking status at Tromsø 4 and Tromsø 7 were combined into one 
variable with four categories: Ex-smoker (No - Yes, previously), daily 
smoker (Yes - Yes, now), never smoker (No - Never) and quitter (Yes - 
Yes, previously). We excluded participants in the two remaining 
categories, those who started smoking or relapsed (No - Yes, now) and 
those who identified themselves as a daily smoker in Tromsø 4 and never 
smoker in Tromsø 7. In the analysis of two consecutive surveys, smoking 
status was defined similarly. 
2.4. Statistical methods 
In all analyses, sex and ten-year birth cohorts were used as cate-
gorical variables. Generalized estimation equations (GEE), with an 
exchangeable co-variance matrix, were used for estimation of mean 
BMI. GEE and logistic regression were used for estimation of prevalence 
of obesity and daily smoking. Robust standard deviation and asymptotic 
normality of the estimators were used to derive confidence intervals. 
The probability density functions of BMI were estimated by kernel 
density estimation, using Gaussian kernels with Silverman’s rule of 
thumb bandwidth selectors. 
To compute BMI change under a scenario where no one quit smok-
ing, we first note that the mean BMI change μ can be written as 
μ =
∑
pi μi, (1)  
where pi and μi is the proportion and mean BMI change, respectively, in 
smoking status group i. The formula (1) follows from the law of double 
expectation. The proportion of quitters, say p1, is distributed to one or 
more of the other groups (i ∕= 1) and then set equal to zero, i.e., p1 = 0 
and 
∑
pi = 1. We chose to distribute the proportion of quitters to 
smokers. We performed a sensitive analysis with educational level and 
body mass index at baseline included as confounders (Supplementary 
Tables 2 and 3) and found that the adjusted estimates were within the 
confidence intervals of the corresponding unadjusted estimates. 
All of the analyses were conducted in R (R Core Team, 2020), and 
most figures were made with the R-package ggplot2 (Wickham, 2016). 
The p-values are for two-sided tests. 
3. Results 
3.1. Daily smoking 
In total, the prevalence of daily smoking was reduced over the 
21 years between Tromsø 4 and Tromsø 7 by 22 percentage points. This 
figure ranged from 21% to 24% in the six groups defined by birth cohorts 
and gender (Table 1). We observed a larger decline from Tromsø 5 (year 
2001) and onwards, which can also be seen in Supplementary Table 4 
and Supplementary Fig. 2. 
3.2. Mean BMI and obesity 
Prevalence of obesity increased from the range of 5% -12% in Tromsø 
4 to the range of 21% -26% in Tromsø 7 (Table 1, Supplementary Fig. 3). 
In Tromsø 4, the oldest birth cohort (1940–1949) had a higher preva-
lence of obesity compared to those born 1950–1969. However, the 
oldest had a smaller change over the 21 years (p < 0.0001), resulting in 
only minor differences in BMI between the birth cohorts in Tromsø 7. 
Mean BMI increased at each consecutive survey for all groups and 
surveys (p < 0.0001), except for men born 1940–1949 in Tromsø 5–6 
where the increase of 0.1 kg/m2 was not statistically significant 
(p = 0.125) (Table 1). The magnitude of change in mean BMI over 
21 years (ΔBMI) decreased with age: those born 1940–1949 had smaller 
ΔBMI than participants born 1950–1959 (p < 0.0001 for both genders) 
and those born 1950–1959 had smaller ΔBMI than participants born 
1960–1969 (p < 0.0001 for both genders). 
The increase in obesity and mean BMI between Tromsø 4 
(1994–1995) and Tromsø 7 (2015–2016) can also be seen from the 
distributions in Fig. 1. 
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3.3. Change in BMI by smoking status and scenario 
The change in mean BMI over 21 years by smoking status is shown in 
Fig. 2. In each group (gender and birth cohort) quitters had a larger 
increase in mean BMI compared to the other three smoking subgroups 
(p < 0.0001). In particular, compared to never-smokers, the excessive 
BMI gain ranged from 1.3 to 1.9 kg/m2 over 21 years (Supplementary 
Table 5). 
Quitters between consecutive surveys also had an excessive BMI gain 
(Supplementary Fig. 4 and Supplementary Table 6). Table 2 shows the 
difference in BMI gain between never-smokers and quitters, over 
21 years and between consecutive surveys. 
The mean BMI gain in the population between Tromsø 4 and Tromsø 
7 was 2.7 kg/m2. The scenario where none quit smoking would imply a 
13% reduction, to a hypothetical BMI gain of 2.3 kg/m2. We observed 
differences in the attributable fractions between the birth cohorts, e.g., 
6% and 7% in the birth cohort 1960–1969 and 24% and 28% in the birth 
cohort 1940–1949, in women and men, respectively (Table 3). 
4. Discussion 
In this longitudinal population study with a follow-up time of 
21 years, we found that the prevalence of daily smoking was reduced by 
22 percentage points in the study population while the prevalence of 
obesity increased substantially. The youngest had the largest increase in 
the prevalence of obesity with 4–5 times more obese people in 
2015–2016 than in 1994–1995. Furthermore, those who quit smoking 
between two surveys had a significant excessive BMI gain compared to 
the other three smoking subgroups. Our results indicate that the major 
part of the excessive gain occurred during the first six to eight years after 
quitting, and also that quitting smoking contributed to the increased 
BMI at the population level, though the attributable fraction was relative 
low (13% in total). However, substantial age-related differences were 
noted and in the older part of the study population, approximately 25% 
of the increase in BMI could be attributed to smoking cessation. 
This study confirms findings from the Framingham Heart Study (Jain 
et al. (2016), of an excessive body weight gain over two decades 
following smoking cessation. Jain et al. only compared quitters to 
smokers, but smokers were further split into subgroups based on number 
of cigarettes per day. In contrast, we treated smokers as one group, but 
also included ex-smokers and never-smokers as there is no reason to a 
priori assume that they did not contribute to the obesity epidemic. 
Indeed, we found that all smoking subgroups in our study (including ex- 
smokers and never-smokers) had a significant BMI gain, which point 
towards other factors to explain the obesity epidemic in addition to 
smoking cessation. The fact that the youngest had the largest increase in 
BMI is in line with findings from other population-based cohort studies 
(Løvsletten et al., 2020). Our study on smoking related weight gain adds 
to previous findings on longitudinal changes in BMI in the Tromsø Study 
Table 1 
Prevalence of daily smoking, obesity and mean body mass index according to survey and birth cohort. The Tromsø Study 1994–2016.  
Sex Year born Survey years Δ21 yearsa 
Tromsø 4 Tromsø 5 Tromsø 6 Tromsø 7 
1994–1995 2001 2007–2008 2015–2016   
Daily smoking (%)  
Women 1940–1949 36 30 21 14 − 22 
1950–1959 41 36 26 18 − 24 
1960–1969 38 34 25 18 − 20 
Men 1940–1949 36 32 19 12 − 24 
1950–1959 36 34 20 15 − 21 
1960–1969 37 34 21 15 − 22    
Obesity (%)  
Women 1940–1949 12 21 22 25 14 
1950–1959 6 10 16 21 15 
1960–1969 5 12 17 24 18 
Men 1940–1949 12 24 23 25 14 
1950–1959 8 15 19 25 18 
1960–1969 6 14 20 26 19    
Mean body mass index (kg/m2)  
Women 1940–1949 25.1 26.6 27.0 27.4 2.3 
1950–1959 23.8 25.3 26.0 26.8 3.0 
1960–1969 23.3 25.1 25.9 26.9 3.6 
Men 1940–1949 26.2 27.5 27.6 27.8 1.6 
1950–1959 25.4 26.6 27.3 27.8 2.4 
1960–1969 24.9 26.4 27.2 28.0 3.2  
a Tromsø 7–Tromsø 4. 
Fig. 1. Distributions of body mass index (BMI) among participants, born 
1940–1969, attending both Tromsø 4 (1994–1995) and Tromsø 7 (2015–2016). 
Survey years indicated in legend. The Tromsø Study. 
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(Jacobsen and Aars, 2015, and Løvsletten et al., 2020). Changes in BMI 
by smoking status has been published for a shorter time interval between 
Tromsø 4 and Tromsø 5 (Sneve and Jorde, 2008). 
The small attributable fraction of smoking cessation on BMI gain in 
the youngest age group can be understood from i) Eq. (1) together with 
the fact that quitters are only a minority of the population and ii) the 
other smoking subgroups also gained considerable weight. The pro-
portions of quitters were similar across age groups. However, a greater 
relative difference between quitters and the other subgroups, implied a 
higher attributable fraction in the oldest birth cohorts, which may partly 
be explained by survival bias. Our reasoning is that smokers with high 
BMI have an increased mortality, which is followed by a lower BMI in 
the smoking group and, in turn, a higher attributable fraction. 
The BMI gain associated with smoking cessation may be limited to 
the first years following abstinence. Our results (Table 2), though 
limited to the sampling scale of 6–8 years, are in accordance with this 
hypothesis. The group of ex-smokers had BMI gain similar to never- 
smokers. Ex-smokers reported to be former daily smokers, but did not 
smoke at any of the two surveys, whereas quitters were daily smokers in 
the first survey and had quit in the second survey. This could be inter-
preted as ex-smokers quit daily smoking prior to the first survey which 
further strengthens the evidence that the excessive BMI gain following 
smoking cessation took place the first years after abstinence (Travier 
et al., 2012). The exact mechanism through which nicotine regulates 
weight is still not clearly understood. Post-cessation weight gain, as 
found in this and other population-based cohort studies, are also 
Fig. 2. Changes in body mass index over 21 years, by smoking status, sex, and year born, with 95% confidence intervals. The Tromsø Study 1994–2016.  
Table 2 
Excessive body mass index gain (kg/m2) for those who quit smoking, compared to never-smokers. 95% confidence intervals in parentheses. The Tromsø Study 
1994–2016.  
Sex Year born Tromsø 4–5 Tromsø 5–6 Tromsø 6–7 Tromsø 4–7 
Δt = 7a Δt = 6a Δt = 8a Δt = 21a 
Women 1940–1949 1.2 (0.7, 1.6) 1.9 (1.5, 2.4) 2.0 (1.6, 2.4) 1.9 (1.5, 2.2) 
1950–1959 1.6 (0.8, 2.4) 1.2 (0.4, 2.0) 1.6 (1.2, 2.1) 1.6 (1.3, 1.9) 
1960–1969 0.8 (0.0, 1.5) 0.4 (− 0.5, 1.3) 1.8 (1.4, 2.2) 1.3 (0.9, 1.6) 
Men 1940–1949 0.5 (− 0.1, 1.2) 1.1 (0.5, 1.7) 1.7 (1.3, 2.1) 1.6 (1.2, 1.9) 
1950–1959 1.2 (0.4, 2.0) 0.6 (− 0.3, 1.5) 1.6 (1.1, 2.1) 1.6 (1.2, 1.9) 
1960–1969 1.2 (0.3, 2.1) 1.6 (0.6, 2.6) 0.7 (0.3, 1.1) 1.3 (0.9, 1.7)  
a Years between surveys. 
Table 3 
Change in body mass index (BMI, kg/m2) over 21 years; observed and in a 
scenario where none quit smoking. 95% confidence intervals in parentheses. The 
Tromsø Study 1994–2016.  
Sex Year born ΔBMI ΔBMI scenario % reductiona 
Women 1940–1949 2.3 (2.1, 2.6) 1.8 (1.5, 2.1) 24 (21, 28) 
1950–1959 3.0 (2.8, 3.2) 2.6 (2.3, 2.8) 15 (14, 17) 
1960–1969 3.6 (3.3, 3.8) 3.3 (3.1, 3.6) 6 (6, 7) 
Men 1940–1949 1.7 (1.4, 1.9) 1.2 (0.9, 1.5) 28 (22, 37) 
1950–1959 2.4 (2.2, 2.6) 2.0 (1.8, 2.3) 16 (14, 18) 
1960–1969 3.2 (2.9, 3.5) 3.0 (2.7, 3.3) 7 (6, 9)  
a ΔBMI − ΔBMI scenario
ΔBMI
× 100 
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observed in rodent models where both rats and mice experience weight 
gain during nicotine withdrawal (Calarco and Picciotto, 2020). Previous 
studies have found an indirect effect through increased energy intake 
following cessation, and possibly also physical activity change, as well as 
a direct effect of nicotine-related metabolic changes (Bush et al., 2016). 
In this study we do not have access to data on physical activity and 
energy intake, so our results are limited to the total effect of smoking 
cessation on BMI change. 
It has been suggested that weight concerns should be taken into ac-
count in tobacco dependence treatment (Luostarinen et al., 2013). The 
initial weight gain following abstinence may cause some to relapse 
(Pisinger and Jorgensen, 2007). Thus, offering information and support 
to maintain body weight after smoking cessation may be of importance 
in order to reduce the probability of relapse. It is important to 
communicate that a possible post-cessation weight gain is much 
healthier compared to continuing smoking (Siahpush et al., 2014). 
This study shows a substantial decrease in the prevalence of daily 
smokers, which we believe is due to a variety of legislative measures that 
have been implemented since the Norwegian Tobacco Act entered into 
force in 1975 (Helsedirektoratet, 2020). While appreciating that we 
have come a long way in fighting tobacco smoking, targeting cessation 
for the remaining group of smokers should remain a priority. 
4.1. Strengths and limitations 
We acknowledge that the results presented, in particular the preva-
lences, may not be representative for the group of non-participants. In 
the population based HUNT study Langhammer et al. (2012) found that 
non-participants were likely to be more unhealthy, with a higher prev-
alence of daily smoking though with a lower BMI. We have previously 
found that consistent attendees to Tromsø 2 – Tromsø 4 had lower 
mortality than those who only attended Tromsø 4, although had been 
invited to all three surveys (Jacobsen et al., 2012). However, the Tromsø 
Study has a high attendance (range 65–79% in Tromsø 4–7), which is a 
significant strength of this study. Another strength is that height and 
weight were measured, as opposed to self-reported which is prone to 
bias (Gorber et al., 2007). Participants in the Tromsø Study reported 
smoking habits on self-administered questionnaires which probably 
means that the number of daily smokers are under-reported (Løchen 
et al., 2017) and also that there may be some misclassification in the 
smoking subgroups. Validation studies in Finland and Norway have 
shown a high degree of concordance between self-reported smoking and 
biological markers of smoking (Foss et al., 1998; Vartiainen et al., 2002). 
Thus, there is little reason to believe that the information bias from self- 
reported smoking has had any substantial effect on the results presented. 
In the analysis of BMI change by smoking status we did not model all 
four surveys jointly, which can be seen as a limitation. On the other 
hand, the statistical methods we used are simple and well-known. A 
possible challenge in using all four surveys is the number of possible 
smoking status combinations (2 × 33 = 54) and missing data. 
5. Conclusion 
We conclude that smoking cessation contributed to an observed in-
crease in obesity in the population, but was probably not the most 
important factor. Public health interventions should continue to target 
smoking cessation, and also target obesity prevention. 
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